Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2026-03-08 @ 4:44 AM
Study NCT ID:
NCT03215069
Status:
COMPLETED
Last Update Posted:
2025-03-07
First Post:
2017-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes
Sponsor:
Mount Sinai Hospital, Canada
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
16-0226-A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |